Increased sarcolemmal permeability as an early event in experimental septic cardiomyopathy: A potential role for oxidative damage to lipids and proteins

Shock

Volumn 33, Issue 3, 2010, Pages 322-331

  Celes, Mara R N ^a   Torres Dueñas, Diego ^b   Prado, Cibele M ^a   Campos, Erica C ^a   Moreira, Jorge E ^a   Cunha, Fernando Q ^b   Rossi, Marcos A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Departments of Pharmacology   (Brazil)

Author keywords

4 hydroxy 2 nonenal (4 HNE); Nitrotyrosine (NT); Oxidative damage; Sarcolemmal permeability; Sepsis; Septic cardiomyopathy

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; CHEMOKINE; CYTOKINE; FREE RADICAL; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MEMBRANE LIPID; PROTEIN; SCAVENGER; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CARDIOMYOPATHY; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTRON MICROSCOPY; EXPERIMENTAL MODEL; HEART MUSCLE CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; SARCOLEMMA; SEPSIS;

ACTINS; ALDEHYDES; ANIMALS; CARDIOMYOPATHIES; CECUM; DOWN-REGULATION; LIGATION; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; MYOCARDIUM; MYOSINS; PERMEABILITY; PROTEINS; PUNCTURES; SARCOLEMMA; SEPSIS;

EID: 77149135587     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181b38ef6     Document Type: Article

References (38)

1. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100:483-490, 1984.
2. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP: Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113:227-242, 1990.
3. Muller-Werdan U, Buerke M, Ebelt H, Heinroth KM, Herklotz A, Loppnow H, RuQ M, Schlegel F, Schlitt A, Schmidt HB, et al.: Septic cardiomyopathyVa not yet discovered cardiomyopathy? Exp Clin Cardiol 11:226-236, 2006.
4. Rossi MA, Celes MR, Prado CM, Saggioro FP: Myocardial structural changes in long-term human severe sepsis/septic shock may be responsible for cardiac dysfunction. Shock 27:10-18, 2007.
5. Flierl MA, Rittirsch D, Huber-Lang MS, Sarma JV, Ward PA: Molecular events in the cardiomyopathy of sepsis. Mol Med 14:327-336, 2008.
6. Arlati S, Brenna S, Prencipe L, Marochi A, Casella GP, Lanzani M, Gandini C: Myocardial necrosis in ICU patients with non-cardiac disease: a prospective study. Intensive Care Med 26:31-37, 2000.
7. ver Elst KM, Spapen HD, Nguyen DN, Garbar C, Huyghens LP, Gorus FK: Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 46:650-657, 2000.
8. Mehta MJ, Khan IA, Gupta V, Jani K, Gowda RM, Smith PR: Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 95:13-17, 2004.
9. Gotloib L, Shostak A, Galdi P, Jaichenko J, Fudin R: Loss of microvascular negative charges accompanied by interstitial edema in septic rats' heart. Circ Shock 36:45-56, 1992.
10. Coalson JJ, Hinshaw LB, Guenter CA, Berrel EL, Greenfield LJ: Pathophy-siologic responses of the subhuman primate in experimental septic shock. Lab Invest 32:561-569, 1975.
11. Hersch M, Gnidec AA, Bersten AD, Troster M, Rutledge FS, Sibbald WJ: Histologic and ultrastructural changes in nonpulmonary organs during early hyperdynamic sepsis. Surgery 107:397-410, 1990.
12. Solomon MA, Correa R, Alexander HR, Koev LA, Cobb JP, Kim DK, Roberts WC, Quezado ZM, Scholz TD, Cunnion RE, et al.: Myocardial energy metabolism and morphology in a canine model of sepsis. Am J Physiol 266:H757-H768, 1994.
13. Schlag G, Redl H, van Vuuren CJ, Davies J: Hyperdynamic sepsis in baboons: II. Relation of organ damage to severity of sepsis evaluated by a newly developed morphological scoring system. Circ Shock 38:253-263, 1992.
14. Goddard Cm, Allard MF, Hogg JC, Walley KR: Myocardial morphometric changes related to decreased contractility after endotoxin. Am J Physiol 270:H1446-H1452, 1996.
15. Piper RD, Li FY, Myers ML, Sibbald WJ: Structure-function relationships in the septic rat heart. Am J Respir Crit Care Med 156:1473-1482, 1997.
16. Zhou M, Wang P, Chaudry IH: Cardiac contractility and structure are not significantly compromised even during the late hemodynamic stage of sepsis. Shock 9:352-358, 1998.
17. Hoffstein S, Gennaro DE, Fox AC, Hrsch J, Streuli F, Weismann G: Colloidal lanthanum as a marker for impaired plasma membrane permeability in ischemic dog myocardium. Am J Pathol 79:207-218, 1975.
18. Camilleri JP, Joseph D, Amat D, Fabiani JN: Impaired sarcolemmal membrane permeability in reperfused ischemic myocardium. Ultrastructural tracer study. Virchows Arch A Pathol Anat Histol 388:69-76, 1980.
19. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shockVa review of laboratory models and a proposal. J Surg Res 29:189-201, 1980.
20. Celes MR, Torres-Dueñas D, Alves-Filho JC, Duarte DB, Cunha FQ, Rossi MA: Reduction of gap and adherens junction proteins and intercalated disc structural remodeling in the hearts of mice submitted to severe cecal ligation and puncture sepsis. Crit Care Med 35:2176-2185, 2007.
21. Rodŕiguez M, Cai W-J, Kostin S, Lucchesi BR, Schaper J: Ischemia depletes dystrophin and inhibits protein synthesis in the canine heart: mechanisms of myocardial ischemic injury. J Mol Cell Cardiol 38:723-733, 2005.
22. Ikeda Y, Martone M, Gu Y, Hoshijima M, Thor A, Oh SS, Peterson KL, Ross J Jr: Altered membrane proteins and permeability correlate with cardiac dysfunction in cardiomyopathic hamsters. Am J Physiol Heart Circ Physiol 278:H1362-H1370, 2000.
23. Hinshaw LB: Sepsis/septic shock. Participation of the microcirculation: an abbreviated review. Crit Care Med 24:1072-1078, 1996.
24. Rossi MA, Santos CS: Sepsis related microvascular myocardial damage with the giant cell inflammation and calcification. Virchows Arch 443:87-92, 2003.
25. Chagnon F, Bentourkia M, Lecomte R, Lessard M, Lesur O: Endotoxin-induced heart dysfunction in rats: assessment of myocardial perfusion and permeability and the role of fluid resuscitation. Crit Care Med 34:127-133, 2006.
26. Lam C, Tyml K, Martin C, Sibbald W: Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest 94:2077-2083, 1994.
27. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 166:98-104, 2002.
28. Bateman RM, Sharpe MD, Ellis CG: Bench-to-bedside review: microvascular dysfunction in sepsis-hemodynamics, oxygen transport, and nitric oxide. Crit Care 7:359-373, 2003.
29. Piel DA, Deutschman CS, Levy RJ: Exogenous cytochrome C restores myocardial cytochrome oxidase activity into the late phase of sepsis. Shock 29:612-616, 2008.
30. Verma R, Huang Z, Deutschman CS, Levy RJ: Caffeine restores myocardial cytochrome oxidase activity and improves cardiac function during sepsis. Crit Care Med 37:1397-1402, 2009.
31. Esterbauer H, Schaur RJ, Zollner H: Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81-128, 1991.
32. Uchida K, Stadman ER: Covalent attachment of 4-hydroxynonenal to glyceraldehydes-3-phosphate dehydrogenase. J Biol Chem 268:6388-6393, 1993.
33. +-ATPase. Free Radic Biol Med 20:215-223, 1996.
34. Blasig IE, Grune T, Schönheit K, Rohde E, Jakstadt M, Haseloff RF, Siems WG: 4-Hydroxynonenal, a novel indicator of lipid peroxidation for reperfusion injury of the myocardium. Am J Physiol 269:H14-H22, 1995.
35. Eaton P, Li JM, Hearse DJ, Shattock MJ: Formation of 4-hydroxy-2-nonenalY modified proteins in ischemic rat heart. Am J Physiol 276:H935-H943, 1999.
36. Nakamura K, Kusano KF, Matsubara H, Nakamura Y, Miura A, Nishii N, Banba K, Nagaje F, Myiaji K, Morita H, et al.: Relationship between oxidative stress and systolic dysfunction in patients with hypertrophic cardiomyopathy. J Card Fail 11:117-123, 2005.
37. Torres-Dueñas D, Celes MR, Freitas A, Alves-Filho JC, Spiller F, Dal-Secco D, Dalto VF, Rossi MA, Ferreira SH, Cunha FQ: Peroxynitrite mediates the failure of neutrophil migration in severe polymicrobial sepsis in mice. Br J Pharmacol 152:341-352, 2007.
38. Kooy NW, Lewis SJ, Royall JA, Ye YZ, Kelly DR, Beckman JS: Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite. Crit Care Med 25:812-819, 1997.